Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

Advertising by Adpathway

Amgen Drug Meets Goals of Key Test in Common Autoimmune Disease With No Approved Meds

6 hours ago 3

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

Advertising by Adpathway

Amgen’s dazodalibep led to statistically significant and clinically meaningful results, according to preliminary Phase 3 results in Sjögren’s disease. This fusion protein could compete against a Novartis antibody under an FDA review that could make it the first Sjögren’s therapy.

The post Amgen Drug Meets Goals of Key Test in Common Autoimmune Disease With No Approved Meds appeared first on MedCity News.

Read Entire Article

Start the new Vibrations with a Medbed Franchise today!

Protect your whole family with Quantum Orgo-Life® devices

Advertising by Adpathway